114 related articles for article (PubMed ID: 9831320)
1. Clinical and basic studies on the G-1 column, a new extracorporeal therapeutic device effective in controlling rheumatoid arthritis.
Kyogoku M; Kasukawa R
Inflamm Res; 1998 Oct; 47 Suppl 3():S166-76. PubMed ID: 9831320
[TBL] [Abstract][Full Text] [Related]
2. Granulocytapheresis in the treatment of patients with rheumatoid arthritis.
Ohara M; Saniabadi AR; Kokuma S; Hirata I; Adachi M; Agishi T; Kasukawa R
Artif Organs; 1997 Sep; 21(9):989-94. PubMed ID: 9288869
[TBL] [Abstract][Full Text] [Related]
3. Effect of G-1 column (Adacolumn) therapy in rats with adjuvant arthritis on the migration and immunoreactivity of peripheral and splenic leukocytes.
Nakazato S; Takase H; Yanagihara Y; Issekutz TB; Issekutz AC; Takai M; Kyogoku M
Mod Rheumatol; 2005; 15(4):249-57. PubMed ID: 17029073
[TBL] [Abstract][Full Text] [Related]
4. Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1.
Fujimori J; Yoshino S; Koiwa M; Hirai H; Shiga H; Hayama N; Iino Y
Rheumatol Int; 1996; 15(5):175-80. PubMed ID: 8717100
[TBL] [Abstract][Full Text] [Related]
5. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis.
Kashiwagi N; Hirata I; Kasukawa R
Ther Apher; 1998 May; 2(2):134-41. PubMed ID: 10225715
[TBL] [Abstract][Full Text] [Related]
6. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study.
Nagashima M; Yoshino S; Tanaka H; Yoshida N; Kashiwagi N; Saniabadi AR
Rheumatol Int; 1998; 18(3):113-8. PubMed ID: 9833252
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic cytapheresis for inflammatory bowel disease.
Sawada K; Shimoyama T
Ther Apher; 1998 May; 2(2):90-2. PubMed ID: 10225705
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal granulocytapheresis for cancer and rheumatoid arthritis.
Yonekawa M; Kawamura A; Komai T; Agishi T; Adachi M
Transfus Sci; 1996 Sep; 17(3):463-72. PubMed ID: 10163555
[TBL] [Abstract][Full Text] [Related]
9. Partial remission of refractory RA after Adacolumn cytapheresis: a case report.
Bazzichi L; Giuliano T; Rossi A; Mazzoni A; Grazzini T; De Feo F; Giacomelli C; Scatena F; Bombardieri S
Rheumatol Int; 2008 Jan; 28(3):295-7. PubMed ID: 17684748
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects.
Ramlow W; Emmrich J; Ahrenholz P; Sparmann G; Kashiwagi N; Franz M; Yokoyama T; Yoshikawa T
J Clin Apher; 2005 Jul; 20(2):72-80. PubMed ID: 15892085
[TBL] [Abstract][Full Text] [Related]
11. Leukocytapheresis in rheumatoid arthritis.
Hidaka T; Hashiba Y; Kubo K; Kai Y; Maeda K
Transfus Apher Sci; 2017 Oct; 56(5):698-702. PubMed ID: 28918917
[TBL] [Abstract][Full Text] [Related]
12. Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood.
Takeda Y; Hiraishi K; Takeda H; Shiobara N; Shibusawa H; Saniabadi AR; Adachi M; Kawata S
Inflamm Res; 2003 Jun; 52(7):287-90. PubMed ID: 12861393
[TBL] [Abstract][Full Text] [Related]
13. Selective adsorption of human CD4 T cells.
Matsuo H; Goto H; Kambara C; Fukudome T; Mizota T; Onodera H; Yoshida M; Shibuya N
Ther Apher Dial; 2004 Jun; 8(3):194-6. PubMed ID: 15154870
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: evidence that GCAP removes Mac-1-expressing neutrophils.
Kanekura T; Hiraishi K; Kawahara K; Maruyama I; Kanzaki T
Ther Apher Dial; 2006 Jun; 10(3):247-56. PubMed ID: 16817789
[TBL] [Abstract][Full Text] [Related]
15. Down-modulation of toll-like receptor 2 expression on granulocytes and suppression of interleukin-8 production due to in vitro treatment with cellulose acetate beads.
Hidaka M; Fukuzawa K
Ther Apher Dial; 2011 Dec; 15(6):572-8. PubMed ID: 22107694
[TBL] [Abstract][Full Text] [Related]
16. Removal of hepatitis C virus by G-1 beads in sera from patients with chronic hepatitis C.
Moriyama M; Kaneko M; Matsumura H; Fukushima A; Aoki H; Tanaka N; Kuroda K; Shimizu K; Hiraishi K; Arakawa Y
Intervirology; 2005; 48(2-3):84-8. PubMed ID: 15812179
[TBL] [Abstract][Full Text] [Related]
17. Preliminary studies for the development of a second generation granulocytapheresis (G-CAP) column. Part II: in vitro and ex vivo studies.
Miyamoto H; Takaba J; Ohta K; Motomura T; Sugita Y; Nosé Y
J Artif Organs; 2011 Dec; 14(4):342-7. PubMed ID: 21713519
[TBL] [Abstract][Full Text] [Related]
18. Pilot clinical study of Adacolumn cytapheresis in patients with systemic lupus erythematosus.
Soerensen H; Schneidewind-Mueller JM; Lange D; Kashiwagi N; Franz M; Yokoyama T; Ramlow W
Rheumatol Int; 2006 Mar; 26(5):409-15. PubMed ID: 16189656
[TBL] [Abstract][Full Text] [Related]
19. Concentration of activated T lymphocytes in extracorporeal blood circulation for plasma separation.
Ijichi S; Mishima M; Matsuda T; Izumihara T; Kojima K; Niimura T; Maruyama I; Osame M
J Clin Apher; 1991; 6(2):88-9. PubMed ID: 1938996
[TBL] [Abstract][Full Text] [Related]
20. Selective in vivo removal of rheumatoid factor by an extracorporeal treatment device in rheumatoid arthritis patients.
Lazarus HM; Cohen SB; Clegg DO; Menitove JE; Sorin SB; Hinkle S; Markenson JA; Saal S; Goodnough LT; Fleischmann RM
Transfusion; 1991 Feb; 31(2):122-8. PubMed ID: 1996481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
